In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeuroSigma Inc.

www.neurosigma.com

Latest From NeuroSigma Inc.

Pacts In Medtech: BI, Inflammasome Work On Retinal Disease; Takeda And Prometheus Take On IBD

Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, research and development partnerships and commercial collaborations. This edition covers industry pacts that were signed in September and October 2019.

Pacts in Medtech Deals

NeuroSigma Monarch eTNS Becomes The First FDA-Cleared ADHD Device

The de novo clearance is based on the results of a 62-patient phase II sham-controlled trial. Patients in the treatment group showed more improvement in attention deficit hyperactivity disorder symptoms over four weeks than patients treated with a placebo device.

Approvals Clinical Trials

Neuromodulation Start-Ups: Abundant Funding, Slow Exits

The field of neuromodulation has produced numerous start-ups and a decent amount of fundraising activity over the past six years, but exits are scarce.

Medical Device Deals

Medical Device Deals Update, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.

Medical Device Deals
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NeuroSigma Inc.
  • Senior Management
  • Leon Ekchian, PhD, Pres. & CEO
    Sam Wild, CFO
    Colin P Kealey, MD, VP, Advanced Dev. & Medical Affairs
    Ian A Cook, MD, SVP, CMO
  • Contact Info
  • NeuroSigma Inc.
    Phone: (310) 479-3100
    10960 Wilshire Blvd.
    Ste. 1910
    Los Angeles, CA 90024
    USA
UsernamePublicRestriction

Register